The Society for Immunotherapy of Cancer (SITC), in collaboration with the European Cancer Patient Coalition (ECPC), hosted a patient-focused webinar on the promise of immunotherapy to treat cancer on January 30th, 2018. This version of our webinar contains slides and subtitles in Hindi.This webinar is produced with generous support from EMD Serono. EMD Serono, is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada.
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.
SITC Cancer Immunotherapy Guidelines https://www.sitcancer.org/research/cancer-immunotherapy-guidelines
Journal for ImmunoTherapy of Cancer https://jitc.biomedcentral.com/articles
Patient Resource Guides https://www.sitcancer.org/connectedold/patient
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org